Antiviral activity of (+)-sattabacin against varicella zoster

Bioorganic and Medicinal Chemistry Letters

Volumn 23, Issue 2, 2013, Pages 562-564

  Mancha, Serena R ^a   Regnery, Christopher M ^a   Dahlke, Joshua R ^a   Miller, Kenneth A ^a   Blake, David J ^a  

^a FORT LEWIS COLLEGE   (United States)

Author keywords

Antiviral; Sattabacin; Varicella zoster

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; NATURAL PRODUCT; PENCICLOVIR; PHENYLALANINE; SATTABACIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL VIABILITY; CRYSTAL STRUCTURE; CYTOTOXICITY; DIAZOTIZATION; DNA MICROARRAY; DRUG STRUCTURE; DRUG SYNTHESIS; FIBROBLAST; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IC 50; NONHUMAN; SIGNAL TRANSDUCTION; VARICELLA ZOSTER VIRUS; VERO CELL; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELL SURVIVAL; CELLS, CULTURED; HERPESVIRUS 3, HUMAN; HEXANONES; HUMANS; MOLECULAR STRUCTURE;

HUMAN HERPESVIRUS 3;

EID: 84871711841     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2012.11.017     Document Type: Article

References (16)

1. G. Lampis, D. Deidda, C. Maullu, M.A. Madeddu, R. Pompei, F.D. Monache, and G. Satta J. Antibiot. 48 1995 967
2. J.W. Gnann Jr. Antiviral Therapy of Varicella-Zoster Virus Infections A. Arvin, G. Campadelli-Fiume, E. Mocarski, Human Herpesviruses: Biology, Therapy, and, Immunoprophylaxis 2007 Cambridge University Press Cambridge Chapter 65
3. N.H. Mueller, D.H. Gilden, R.J. Cohrs, R. Mahalingam, and M.A. Nagel Neurol. Clin. 26 2008 675
4. M.M. Davis, M.S. Patel, and A. Gebremariam Pediatrics 114 2004 786
5. K. Stratton, A. Ford, E. Rusch, and E.W. Clayton Adverse Effects of Vaccines: Evidence and Causality 2012 The National Academies Press Washington, DC
6. S.J. Olshansky, D.P. Goldman, Y. Zheng, and J.W. Rowe Milbank Q. 87 2009 842
7. H.J. Schaeffer, L. Beauchamp, P. De Miranda, G.B. Elion, D.J. Bauer, and P. Collins Nature 272 1978 583
8. C.M. Perry, and D. Faulds Drugs 52 1996 754
9. M.R. Keating Mayo Clin. Proc. 74 1999 1266
10. D.W. Kimberlin, C.S. Crumpacker, S.E. Straus, K.K. Biron, W.L. Drew, F.G. Hayden, M. McKinlay, D.D. Richman, and R.J. Whitley Antiviral Res. 26 1995 423
11. M.R. Aronoff, N.A. Bourjaily, and K.A. Miller Tetrahedron Lett. 51 2010 6375
12. T. Storz, P. Dittmar, P.F. Fauquex, P. Marschal, W.U. Lottenbach, and H. Steiner Org. Proc. Res. Dev. 7 2003 559
13. J. O'Brien, I. Wilson, T. Orton, and F. Pognan Eur. J. Biochem. 267 2000 5421
14. D.L. Krah, T.L. Schofield, and P.J. Provost J. Virol. Methods 27 1990 319
15. A.M. Campbell, T.T. Eckdahl, E. Fowlks, L.J. Heyer, L.L. Mays Hoopes, M.L. Ledbetter, and A.G. Rosenwald Science 311 2006 1103
16. N.G. Sharpe, D. Isenberg, D.G. Williams, and D.S. Latchman J. Autoimmun. 2 1989 701